BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27986226)

  • 1. Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo.
    Maussang D; Rip J; van Kregten J; van den Heuvel A; van der Pol S; van der Boom B; Reijerkerk A; Chen L; de Boer M; Gaillard P; de Vries H
    Drug Discov Today Technol; 2016 Jun; 20():59-69. PubMed ID: 27986226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats.
    Rip J; Chen L; Hartman R; van den Heuvel A; Reijerkerk A; van Kregten J; van der Boom B; Appeldoorn C; de Boer M; Maussang D; de Lange EC; Gaillard PJ
    J Drug Target; 2014 Jun; 22(5):460-7. PubMed ID: 24524555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of glutathione conjugation on the transcellular transport process of PEGylated liposomes across the blood brain barrier.
    Reginald-Opara JN; Tang M; Svirskis D; Chamley L; Wu Z
    Int J Pharm; 2022 Oct; 626():122152. PubMed ID: 36055442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study.
    Lindqvist A; Rip J; Gaillard PJ; Björkman S; Hammarlund-Udenaes M
    Mol Pharm; 2013 May; 10(5):1533-41. PubMed ID: 22934681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic Caelyx,(®)/Doxil(®)--a cerebral open flow microperfusion pilot study.
    Birngruber T; Raml R; Gladdines W; Gatschelhofer C; Gander E; Ghosh A; Kroath T; Gaillard PJ; Pieber TR; Sinner F
    J Pharm Sci; 2014 Jul; 103(7):1945-1948. PubMed ID: 24801480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference?
    Hu Y; Gaillard PJ; de Lange ECM; Hammarlund-Udenaes M
    Eur J Pharm Biopharm; 2019 Jun; 139():197-204. PubMed ID: 30951819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries.
    Hülsermann U; Hoffmann MM; Massing U; Fricker G
    J Drug Target; 2009 Sep; 17(8):610-8. PubMed ID: 19694613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.
    Rotman M; Welling MM; Bunschoten A; de Backer ME; Rip J; Nabuurs RJ; Gaillard PJ; van Buchem MA; van der Maarel SM; van der Weerd L
    J Control Release; 2015 Apr; 203():40-50. PubMed ID: 25668771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes.
    Lindqvist A; Rip J; van Kregten J; Gaillard PJ; Hammarlund-Udenaes M
    Pharm Res; 2016 Jan; 33(1):177-85. PubMed ID: 26275529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101).
    Gaillard PJ; Appeldoorn CC; Dorland R; van Kregten J; Manca F; Vugts DJ; Windhorst B; van Dongen GA; de Vries HE; Maussang D; van Tellingen O
    PLoS One; 2014; 9(1):e82331. PubMed ID: 24416140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
    Gaillard PJ; Appeldoorn CC; Rip J; Dorland R; van der Pol SM; Kooij G; de Vries HE; Reijerkerk A
    J Control Release; 2012 Dec; 164(3):364-9. PubMed ID: 22732475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles.
    Xin H; Sha X; Jiang X; Chen L; Law K; Gu J; Chen Y; Wang X; Fang X
    Biomaterials; 2012 Feb; 33(5):1673-81. PubMed ID: 22133551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
    Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
    Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study.
    Salem HF; Ahmed SM; Hassaballah AE; Omar MM
    Drug Des Devel Ther; 2015; 9():3705-27. PubMed ID: 26229435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing Anticancer Effect of Gefitinib across the Blood-Brain Barrier Model Using Liposomes Modified with One α-Helical Cell-Penetrating Peptide or Glutathione and Tween 80.
    Lin KH; Hong ST; Wang HT; Lo YL; Lin AM; Yang JC
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic considerations of nanodelivery to the brain: Using modeling and simulations to predict the outcome of liposomal formulations.
    Lindqvist A; Fridén M; Hammarlund-Udenaes M
    Eur J Pharm Sci; 2016 Sep; 92():173-82. PubMed ID: 27393342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotin and Glutathione Targeting of Solid Nanoparticles to Cross Human Brain Endothelial Cells.
    Veszelka S; Meszaros M; Kiss L; Kota Z; Pali T; Hoyk Z; Bozso Z; Fulop L; Toth A; Rakhely G; Deli MA
    Curr Pharm Des; 2017; 23(28):4198-4205. PubMed ID: 28748755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes.
    Johnsen KB; Moos T
    J Control Release; 2016 Jan; 222():32-46. PubMed ID: 26658072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting liposomes with protein drugs to the blood-brain barrier in vitro.
    Visser CC; Stevanović S; Voorwinden LH; van Bloois L; Gaillard PJ; Danhof M; Crommelin DJ; de Boer AG
    Eur J Pharm Sci; 2005 Jun; 25(2-3):299-305. PubMed ID: 15911226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.
    Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H
    Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.